• Skip to primary navigation
  • Skip to main content
  • +1-757-224-0177
  • 400-860-0210
  • fdahelpdesk
  • 联系我们
  • MyFDA登录
  • COVID-19 个人防护设备
  • 中文
    • English
    • Español
    • Italiano
    • Deutsch
    • Français
    • Portuguese
    • 日本語
Registrar

Registrar

Assistance with U.S. FDA Regulations

  • 中文
    • English
    • Español
    • Italiano
    • Deutsch
    • Français
    • Portuguese
    • 日本語
  • 向FDA注册
  • 服务
    • 向FDA注册
    • 化妝品FDA註冊
    • 认证及合规培训
    • 食品安全计划和FSMA
    • FDA标签
    • UDI与GUDID
    • 主文件
    • TTB Registration
  • 行业
    • 食品和饮料
    • 膳食补充剂
    • 医疗器械
    • 药品
    • 化妆品
    • 其它
  • 资源
    • 资源
    • 新闻
    • 商业活动/研讨会
    • 工具类
  • 关于我们
    • 关于我们
    • 联系我们

The United States Food & Drug Administration and NAFTA

The United States Food & Drug Administration and NAFTA

The North American Free Trade Agreement (NAFTA) helps safeguard the ability of the United States Food and Drug Administration to ensure food safety and quality within North America. NAFTA, effective on January 1, 1994, is an agreement between Canada, US and Mexico designed to increase the scope for the free flow trade and investment among these three countries. The US Food and Drug Administration (US FDA), which participated in the negotiation of NAFTA, has reviewed the US Food and Drug Administration standards for safety, purity and appropriate labeling of foods and has determined that these standards are consistent with the terms of the agreement. As such, no changes in US Food and Drug Administration standards were needed nor proposed to implement NAFTA.

NAFTA does not change existing or future US Food and Drug Administration standards regarding pesticide use, pesticide combined with other chemical residue, or contaminant standards for fresh or processed foods; instead, NAFTA provisions safeguard the ability of the US Food & Drug Administration to ensure food safety. In short, existing US Food and Drug Administration standards will continually be applied to both imported foods and domestically produced foods, and the U.S. will continue to prohibit any food shipments found not to meet pesticide residue or other food safety requirements.

NAFTA has no effect on US Food and Drug Administration laws and regulations in the area of safety, effectiveness and appropriate labeling of human and animal drugs and medical devices. Any products coming into the U.S. must continue to meet all US FDA standards and requirements.

Additionally, NAFTA neither changes nor affects US Food Drug Administration laws and regulations regarding US Food and Drug safety or appropriate labeling of dietary supplements imported in to the U.S.

US FDA and TWG
Within the auspices of NAFTA, three countries have developed a technical working group on pesticides called TWG, serving as a focal point for all issues related to pesticides. TWG’s aim is to ensure that countries can be assured of the legality and safety of foods produced in any of the NAFTA countries. The US Food and Drug Administration is providing trilateral cooperation between Mexico and Canada to enforce the TWG standards.

Article 723(6) makes explicit that any party challenging a US Food and Drug Administration safety measure will have the duty of showing that theUS Food and Drug measure is inconsistent with NAFTA. Whether any particular level of protection is “appropriate” is a social and political judgment reserved for the government applying the measure (see Articles 712(2) and 724). As provided in Article 712, a sanitary measure is to be based on a risk assessment “as appropriate to the circumstances,” and is not to be maintained without scientific basis. The US Food and Drug Administration standards are already based on risk assessments on a scientific basis. These NAFTA requirements help assure that measures applied by the other parties will not unfairly exclude U.S. food exports.

我们的方案

向FDA注册

FDA Compliance Monitor

FDA标签

查看全部

关于我们

关于我们

资源

工具

费用

联系我们

 

评论

地址

商业活动

协会

电话: +1-757-224-0177

传真: +1-757-224-0179

[email protected]

© 2026 Registrar Corp

144 Research Drive Hampton, Virginia 23666 USA
使用条款 | 隐私条例

  • 中文
    • English
    • Español
    • Italiano
    • Deutsch
    • Français
    • Portuguese
    • 日本語
    • Back
  • 向FDA注册
  • 服务
    • 向FDA注册
    • 化妝品FDA註冊
    • 认证及合规培训
    • 食品安全计划和FSMA
    • FDA标签
    • UDI与GUDID
    • 主文件
    • TTB Registration
    • Back
  • 行业
    • 食品和饮料
    • 膳食补充剂
    • 医疗器械
    • 药品
    • 化妆品
    • 其它
    • Back
  • 资源
    • 资源
    • 新闻
    • 商业活动/研讨会
    • 工具类
    • Back
  • 关于我们
    • 关于我们
    • 联系我们
    • Back

通知:未能完成 年FDA注册续期的企业必须重新注册

通知: 未能完成 年医疗器械FDA注册和药品FDA注册续期的企业必须重新注册

立即重新注册

已持有FDA注册的企业必须在 年12月31日前延续其注册

医疗器械注册和药品注册必须在 年12月31日前完成注册续期

立即续期

提醒

美国食品药品管理局(FDA)要求所有食品、药品、 医疗器械注册企业在 年10月1日到12月31日期间延续其注册。

立即续期

通知

美国FDA注册延续时间将在年12月31日截至

若您未能在截止日前完成续期,将需要重新注册。

重新注册或者验证您的注册是否已延续至:

重新注册
验证

限时特惠

即日注册,即可用一年的费用享受18个月的注册和代理人服务有效期

Get Started